Home / Medical Devices / Atrial Fibrillation Devices Market By Product Type (Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Mapping And Recording Systems, Cardiac Monitors, Access Devices, Left Atrial Appendage (LAA) & Closure Devices, Intracardiac Echocardiography (ICE) Systems & Others), By End-Use (Hospitals, Clinics, Ambulatory Surgery Centers (ASCs), Others) - Growth, Share, Opportunities & Competitive Analysis, 2018-2026

Atrial Fibrillation Devices Market By Product Type (Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Mapping And Recording Systems, Cardiac Monitors, Access Devices, Left Atrial Appendage (LAA) & Closure Devices, Intracardiac Echocardiography (ICE) Systems & Others), By End-Use (Hospitals, Clinics, Ambulatory Surgery Centers (ASCs), Others) - Growth, Share, Opportunities & Competitive Analysis, 2018-2026

Published: May 2018 | Report Code: 59137-05-18

Atrial fibrillation devices market to exhibit rapid profitable growth during the forecast period.

The global atrial fibrillation devices market accounted for market value of US$ 4,884.9 Mn in 2017 and expected to attain US$ 17,867.3 Mn by 2026. Worldwide growing geriatric population coupled with rising prevalence of obesity and hypertension are anticipated to nurture the market growth over the forecast period. In addition, technological developments in atrial fibrillation devices and the presence of favorable government initiatives across various countries expected to assist in the market growth.

Geriatric population is prone to develop chronic diseases such as atrial fibrillation and arrhythmia. The World Health Organization (WHO) projected worldwide population aged 60 years and above will upsurge from 962.0 million in 2017 to more than 2.0 billion in 2050 to 3.1 billion by 2100. Increasing prevalence of obesity and hypertension across the world leads to development of atrial fibrillation (AF or Afib). For instance, as per data published by the WHO, in 2016, over 1.9 billion population was overweight, of these more than 650.0 million adults were obese. This population further grew to 2.1 billion that is nearly 30.0% of the world’s population. As per an article published in the Journal of the American Society of Hypertension, worldwide prevalence of hypertension was 1.39 billion in 2010, which is anticipated to reach to 1.56 billion by 2025.

Technological developments in atrial fibrillation devices such as new 3D mapping technology is featured in ablation catheters that decreases fluoroscopy time and radiation dose for patients by tracking real time of device. Moreover, novel techniques such as convergent procedure, focal impulse and rotor modulation (FIRM) ablation, and WATCHMAN left atrial appendage closure (LAAC) procedure are gaining traction across the globe that is increasing the adoption of atrial fibrillation devices.

Market Synopsis

Atrial Fibrillation Devices Market

The electrophysiology ablation catheters segment to hold major chunk of the market over the forecast period

The electrophysiology (EP) ablation catheters segment expected to dominate the market for next nine years owing to rising adoption of radiofrequency and microwave catheter ablation when patients are tolerant to anti-coagulation drugs. Patients who cannot recover from medicines and have symptomatic atrial fibrillation are the major target population for catheter ablation. Moreover, technological advancements such as radiofrequency catheter ablation and microwave-based catheter ablation are supporting the dominance of this segment. The radiofrequency catheter ablation procedure produces less irregular, more dense/homogenous lesions; hence, minimizes the length of procedures.

The cardiac monitors segment is likely to register comparatively higher CAGR over the forecast period due to the emergence of implantable cardiac monitors (ICMs) to monitor atrial fibrillation. The ICMs assess infrequent or potentially asymptomatic arrhythmias, evaluate unexplained syncope, and constantly monitor the electrocardiogram of patients and perform real-time analysis of the heart rhythm for up to 36 months. The ICMs are placed subcutaneously which automatically detect & record abnormal heart rhythms for up to five years. Other cardiac monitors such as holter monitor, event recorder, and mobile cardiac telemetry (MCT) are also used to monitor heart rhythms.

Atrial Fibrillation Devices Market

Hospitals segment contribute maximum to the overall growth of atrial fibrillation devices market

As per the data provided by the Cybermetrics Lab, a research group of the Spanish National Research Council/Consejo Superior de Investigaciones Científicas (CSIC) currently there are more than 16,500 hospitals across the globe. Worldwide surge in the number of hospitals coupled with comparatively higher adoption of atrial fibrillation devices during Afib procedures is supporting the dominance of the hospitals segment. Catheter ablations have become increasingly popular over the years and majorly performed in hospitals.

Atrial Fibrillation Devices Market

Higher spending on Afib and the presence of sophisticated healthcare infrastructure holds North America in dominant position

North America estimated to command the market during 2018 to 2026 due to the presence of sophisticated healthcare infrastructure and higher adoption of advanced technologies in the U.S. and Canada. According to AtriCure, Inc.’s data, U.S. has 6.0 million Afib patients who incurred a total cost of US$ 26.0 billion for the disease in 2017. U.S. holds more than US$ 1.0 billion market for atrial fibrillation devices. Rising prevalence of Afib in the UK, Germany, France and other European countries is also holding substantial market share in 2017. An article published in the European Heart Journal (EHJ) stated that around 4.5 million patients have AF that is forecasted to reach to 17.9 million in Europe by 2060.

Asia Pacific is anticipated to witness fastest market growth in near future owing to the larger population and older age groups that are susceptible to cardiac diseases. Also, growing awareness about Afib procedures, surging geriatric population, and rising healthcare expenditure in India, China, and Japan is expected to contribute to the regional market growth.

Atrial Fibrillation Devices Market

Dominance of established multinational players with strong product portfolio makes market penetration difficult for emerging players

Major players in this space are Medtronic; Boston Scientific Corporation; AtriCure, Inc.; Abbott Laboratories; Hansen Medical; Stereotaxis, Inc.; Biosense Webster, Inc.; Siemens Healthineers; BIOTRONIK SE & Co. KG; and CardioFocus, Inc. In December 2017, Abbott Laboratories launched Confirm Rx insertable cardiac monitor (ICM), a smartphone compatible ICM across India. This device is helping physicians to detect Afib and monitor their patients. In August 2016, in the U.S., Biosense Webster, Inc. launched THERMOCOOL SMARTTOUCH SF Catheter that to be used during catheter ablation procedures. In January 2014, AtriCure, Inc. acquired Endoscopic Technologies, Inc. (Estech), a California-based medical device manufacturing firm in order to strengthen its surgical ablation devices portfolio and to maintain a leadership position in the atrial fibrillation devices market. Abbott Laboratories and GE Healthcare collaborated in May 2015 to improve treatment of Afib patients and to gain a competitive edge. GE's CardioLab sends electrogram signal data to Abbott's RhythmView mapping software that help doctors in quickly diagnosing the source of heart rhythm disorders.

Atrial Fibrillation Devices Market

Historical & Forecast Period

2016 – Historical Year

2017 – Base Year

2018 - 2026 – Forecast Period

This study report represents analysis for each segment from 2016 to 2026 considering 2017 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2018 to 2026.

Report Scope by Segments

Atrial Fibrillation Devices Market

Atrial fibrillation devices market comprises current market trends and dynamics along with quantitative analysis of the global market. The report elucidates thorough information of global atrial fibrillation devices market by segmenting the market in terms of product type, end-use, and geography. This report would guide healthcare professionals and market players in decision-making and strategizing market position.

Product Type Segment (2016–2026; US$ Mn)

  • Electrophysiology Ablation Catheters
  • Electrophysiology Diagnostic Catheters
    • Fixed Diagnostic Catheters
    • Steerable Diagnostic Catheters
    • Others
  • Electrophysiology Mapping and Recording Systems
  • Cardiac Monitors
  • Access Devices
  • Left Atrial Appendage (LAA) & Closure Devices
  • Intracardiac Echocardiography (ICE) Systems & Others

End-use Segment (2016–2026; US$ Mn)

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Others (electrophysiology labs, catheterization laboratories)

Geography Segment (2016–2026; US$ Mn)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • Rest of Middle East & Africa

The current report also comprehends qualitative market assessment factors such as market trends, key market drivers, restraints and opportunities that gives a better market understanding of the overall atrial fibrillation devices market. Furthermore, the report also comprises graphical representation of competitive landscape based on their market initiatives and strategies, product portfolio and business strengths. Key industrial players profiled in the study report are Medtronic; Boston Scientific Corporation; AtriCure, Inc.; Abbott Laboratories; Hansen Medical; Stereotaxis, Inc.; Biosense Webster, Inc.; Siemens Healthineers; BIOTRONIK SE & Co. KG; CardioFocus, Inc.

Key questions answered in this report

  • What are the current market trends and dynamics in the atrial fibrillation market and valuable opportunities for emerging players?
  • Which product contributes to the maximum market share?
  • Which product accounts for the fastest CAGR during the forecast period?
  • Which end-user holds a larger market share and why?
  • What is the impact of pharmaceutical drugs on the atrial fibrillation devices market?
  • Are low and middle-income economies investing in the atrial fibrillation devices market?
  • What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America and Middle East & Africa?

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Market Segmentation
1.3 Research Scope
1.4 Research Methodology
1.4.1 Phase I – Secondary Research
1.4.2 Phase II – Primary Research
1.4.3 Phase III – Expert Panel Review
1.4.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Atrial Fibrillation Devices Market Portraiture
2.2 Global Atrial Fibrillation Devices Market, by Product Type, 2017 (US$ Mn)
2.3 Global Atrial Fibrillation Devices Market, by End-use, 2017 (US$ Mn)
2.4 Global Atrial Fibrillation Devices Market, by Geography, 2017 (US$ Mn)

Chapter 3 Global Atrial Fibrillation Devices Market: Dynamics & Future Outlook
3.1 Market Overview
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Worldwide rising prevalence of obesity and hypertension
3.2.1.2 Technological advances in atrial fibrillation devices
3.2.1.3 Driver 3
3.2.1.4 Driver 4
3.2.2 Challenges
3.2.2.1 Challenge 1
3.2.2.2 Challenge 2
3.2.3 Opportunities
3.2.3.1 Opportunity 1
3.2.3.2 Opportunity 2
3.3 Attractive Investment Proposition, by Geography, 2017
3.4 Competitive Landscape, by Key Players, 2017

Chapter 4 Global Atrial Fibrillation Devices Market, by Product Type, 2016-2026 (US$ Mn)
4.1 Overview
4.2 Electrophysiology Ablation Catheters
4.3 Electrophysiology Diagnostic Catheters
4.3.1 Fixed Diagnostic Catheters
4.3.2 Steerable Diagnostic Catheters
4.3.3 Others (balloon catheters, microcatheters)
4.4 Electrophysiology Mapping and Recording Systems
4.5 Cardiac Monitors
4.6 Access Devices
4.7 Left Atrial Appendage (LAA) & Closure Devices
4.8 Intracardiac Echocardiography (ICE) Systems & Others

Chapter 5 Global Atrial Fibrillation Devices Market, by End-use, 2016-2026 (US$ Mn)
5.1 Overview
5.2 Hospitals
5.3 Clinics
5.4 Ambulatory Surgery Centers (ASCs)
5.5 Others (electrophysiology labs, catheterization laboratories)

Chapter 6 Global Atrial Fibrillation Devices Market, by Geography, 2016-2026 (US$ Mn)
6.1 Overview
6.2 North America Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)
6.2.1 North America Atrial Fibrillation Devices Market, by Product Type, 2016–2026 (US$ Mn)
6.2.2 North America Atrial Fibrillation Devices Market, by End-use, 2016–2026 (US$ Mn)
6.2.3 North America Atrial Fibrillation Devices Market, by Country, 2016–2026 (US$ Mn)
6.2.3.1 U.S.
6.2.3.2 Canada
6.3 Europe Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)
6.3.1 Europe Atrial Fibrillation Devices Market, by Product Type, 2016–2026 (US$ Mn)
6.3.2 Europe Atrial Fibrillation Devices Market, by End-use, 2016–2026 (US$ Mn)
6.3.3 Europe Atrial Fibrillation Devices Market, by Country/Region, 2016–2026 (US$ Mn)
6.3.3.1 U.K.
6.3.3.2 Germany
6.3.3.3 Rest of Europe
6.4 Asia Pacific Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)
6.4.1 Asia Pacific Atrial Fibrillation Devices Market, by Product Type, 2016–2026 (US$ Mn)
6.4.2 Asia Pacific Atrial Fibrillation Devices Market, by End-use, 2016–2026 (US$ Mn)
6.4.3 Asia Pacific Atrial Fibrillation Devices Market, by Country/Region, 2016–2026 (US$ Mn)
6.4.3.1 Japan
6.4.3.2 China
6.4.3.3 Rest of Asia Pacific
6.5 Latin America Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)
6.5.1 Latin America Atrial Fibrillation Devices Market, by Product Type, 2016–2026 (US$ Mn)
6.5.2 Latin America Atrial Fibrillation Devices Market, by End-use, 2016–2026 (US$ Mn)
6.5.3 Latin America Atrial Fibrillation Devices Market, by Country/Region, 2016–2026 (US$ Mn)
6.5.3.1 Brazil
6.5.3.2 Mexico
6.5.3.3 Rest of Latin America
6.6 Middle East & Africa Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)
6.6.1 Middle East & Africa Atrial Fibrillation Devices Market, by Product Type, 2016–2026 (US$ Mn)
6.6.2 Middle East & Africa Atrial Fibrillation Devices Market, by End-use, 2016–2026 (US$ Mn)
6.6.3 Middle East & Africa Atrial Fibrillation Devices Market, by Region, 2016–2026 (US$ Mn)
6.6.3.1 GCC
6.6.3.2 Rest of Middle East & Africa

Chapter 7 Company Profiles
7.1 AtriCure, Inc.
7.2 Boston Scientific Corporation
7.3 AtriCure, Inc.
7.4 Abbott Laboratories
7.5 Hansen Medical
7.6 Stereotaxis, Inc.
7.7 Biosense Webster, Inc.
7.8 Siemens Healthineers
7.9 BIOTRONIK SE & Co. KG
7.10 CardioFocus, Inc.

Note :-

  • This ToC is subject to further refinement as per client request.

FIG. 1 Market Segmentation: Global Atrial Fibrillation Devices Market
FIG. 2 Global Atrial Fibrillation Devices Market: Research Methodology
FIG. 3 Global Atrial Fibrillation Devices Market, by Product Type, 2017 (US$ Mn)
FIG. 4 Global Atrial Fibrillation Devices Market, by End-use, 2017 (US$ Mn)
FIG. 5 Global Atrial Fibrillation Devices Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition, by Geography, 2017
FIG. 7 Competitive Analysis: Global Atrial Fibrillation Devices Market, by Key Players, 2017
FIG. 8 Global Electrophysiology Ablation Catheters Market for Atrial Fibrillation Devices, 2016–2026 (US$ Mn)
FIG. 9 Global Fixed Diagnostic Catheters Market for Atrial Fibrillation Devices, 2016–2026 (US$ Mn)
FIG. 10 Global Steerable Diagnostic Catheters Market for Atrial Fibrillation Devices, 2016–2026 (US$ Mn)
FIG. 11 Global Others Market for Atrial Fibrillation Devices, 2016–2026 (US$ Mn)
FIG. 12 Global Electrophysiology Mapping and Recording Systems Market for Atrial Fibrillation Devices, 2016–2026 (US$ Mn)
FIG. 13 Global Cardiac Monitors Market for Atrial Fibrillation Devices, 2016–2026 (US$ Mn)
FIG. 14 Global Access Devices Market for Atrial Fibrillation Devices, 2016–2026 (US$ Mn)
FIG. 15 Global Left Atrial Appendage (LAA) & Closure Devices Market for Atrial Fibrillation Devices, 2016–2026 (US$ Mn)
FIG. 16 Global Intracardiac Echocardiography (ICE) Systems & Others Market for Atrial Fibrillation Devices, 2016–2026 (US$ Mn)
FIG. 17 Global Hospitals Market for Atrial Fibrillation Devices, 2016–2026 (US$ Mn)
FIG. 18 Global Clinics Market for Atrial Fibrillation Devices, 2016–2026 (US$ Mn)
FIG. 19 Global Ambulatory Surgery Centers (ASCs) Market for Atrial Fibrillation Devices, 2016–2026 (US$ Mn)
FIG. 20 Global Others Market for Atrial Fibrillation Devices, 2016–2026 (US$ Mn)
FIG. 21 U.S. Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)
FIG. 22 Canada Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)
FIG. 23 U.K. Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)
FIG. 24 Germany Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)
FIG. 25 Rest of Europe Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)
FIG. 26 Japan Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)
FIG. 27 China Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)
FIG. 28 Rest of Asia Pacific Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)
FIG. 29 Brazil Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)
FIG. 30 Mexico Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)
FIG. 31 Rest of Latin America Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)
FIG. 32 GCC Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)
FIG. 33 Rest of Middle East & Africa Atrial Fibrillation Devices Market, 2016–2026 (US$ Mn)

TABLE 1 Global Atrial Fibrillation Devices Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 2 Global Electrophysiology Diagnostic Catheters Market for Atrial Fibrillation Devices, 2016–2026 (US$ Mn)
TABLE 3 Global Atrial Fibrillation Devices Market, by End-use, 2016–2026 (US$ Mn)
TABLE 4 Global Atrial Fibrillation Devices Market, by Geography, 2016–2026 (US$ Mn)
TABLE 5 North America Atrial Fibrillation Devices Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 6 North America Atrial Fibrillation Devices Market, by End-use, 2016–2026 (US$ Mn)
TABLE 7 North America Atrial Fibrillation Devices Market, by Country, 2016–2026 (US$ Mn)
TABLE 8 Europe Atrial Fibrillation Devices Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 9 Europe Atrial Fibrillation Devices Market, by End-use, 2016–2026 (US$ Mn)
TABLE 10 Europe Atrial Fibrillation Devices Market, by Country, 2016–2026 (US$ Mn)
TABLE 11 Asia Pacific Atrial Fibrillation Devices Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 12 Asia Pacific Atrial Fibrillation Devices Market, by End-use, 2016–2026 (US$ Mn)
TABLE 13 Asia Pacific Atrial Fibrillation Devices Market, by Country, 2016–2026 (US$ Mn)
TABLE 14 Latin America Atrial Fibrillation Devices Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 15 Latin America Atrial Fibrillation Devices Market, by End-use, 2016–2026 (US$ Mn)
TABLE 16 Latin America Atrial Fibrillation Devices Market, by Country, 2016–2026 (US$ Mn)
TABLE 17 Middle East & Africa Atrial Fibrillation Devices Market, by Product Type, 2016–2026 (US$ Mn)
TABLE 18 Middle East & Africa Atrial Fibrillation Devices Market, by End-use, 2016–2026 (US$ Mn)
TABLE 19 Middle East & Africa Atrial Fibrillation Devices Market, by Country, 2016–2026 (US$ Mn)
TABLE 20 Medtronic: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Boston Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 AtriCure, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Abbott: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Hansen Medical: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Stereotaxis, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Biosense Webster, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Siemens Healthineers: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 BIOTRONIK SE & Co. KG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 CardioFocus, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients